{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:05:49Z","timestamp":1768730749340,"version":"3.49.0"},"reference-count":14,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec><jats:label\/><jats:p>\u00a0\n<jats:boxed-text content-type=\"graphic\" position=\"anchor\"><jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/tid13932-gra-0001-m.png\"><jats:alt-text>image<\/jats:alt-text><\/jats:graphic><\/jats:boxed-text><\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.13932","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T12:53:38Z","timestamp":1660827218000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myalgia in liver transplant recipients after receiving tixagevimab\/cilgavimab for pre\u2010exposure prophylaxis of COVID\u201019: A case series"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3149-6558","authenticated-orcid":false,"given":"Hanna L.","family":"Kleiboeker","sequence":"first","affiliation":[{"name":"Department of Pharmacy University of Wisconsin Hospital and Clinics  Madison Wisconsin USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-9727","authenticated-orcid":false,"given":"Margaret R.","family":"Jorgenson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Wisconsin Hospital and Clinics  Madison Wisconsin USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9379-6332","authenticated-orcid":false,"given":"Jeannina A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Infectious Diseases University of Wisconsin School of Medicine and Public Health  Madison Wisconsin USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1097"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13637"},{"key":"e_1_2_8_4_1","unstructured":"FDA.Fact sheet for healthcare providers: emergency use authorization for Evushel (tixagevimab co\u2010packaged with cilgavimab). Accessed April 26 2022.https:\/\/www.fda.gov\/media\/154701\/download"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13361"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003836"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","unstructured":"Al JurdiA MorenaL CoteM BetheaE AzziJ RiellaLV.Tixagevimab\/cilgavimab pre\u2010exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the Omicron wave. medRxiv;2022. doi:10.1101\/2022.05.17.22274980. medRxiv","DOI":"10.1101\/2022.05.17.22274980"},{"key":"e_1_2_8_8_1","unstructured":"Center for Drug Evaluation and Research.FDA authorizes revisions to Evusheld dosing. February 24 2022. Accessed April 26 2022.https:\/\/www.fda.gov\/drugs\/drug\u2010safety\u2010and\u2010availability\/fda\u2010authorizes\u2010revisions\u2010evusheld\u2010dosing"},{"key":"e_1_2_8_9_1","unstructured":"Tixagevimab and Cilgavimab.Lexicomp. Accessed May 12 2022.https:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/uofwisconsin_f\/7181632?cesid=5bSWTlXlESm&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Devusheld%26t%3Dname%26acs%3Dtrue%26acq%3Devushl#"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2116620"},{"key":"e_1_2_8_11_1","unstructured":"ClinicalTrials.gov.Phase III double\u2010blind placebo\u2010controlled study of azd7442 for post\u2010exposure prophylaxis of COVID\u201019 in adults. Phase III double\u2010blind placebo\u2010controlled study of AZD7442 for post\u2010exposure prophylaxis of COVID\u201019 in adults \u2010 full text view \u2010 ClinicalTrials.gov. Accessed April 26 2022.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04625972"},{"key":"e_1_2_8_12_1","unstructured":"astrazeneca.Update on AZD7442 STORM CHASER trial in post\u2010exposure prevention of symptomatic COVID\u201019. June 15 2022. Accessed June 27 2022.https:\/\/www.astrazeneca.com\/media\u2010centre\/press\u2010releases\/2021\/update\u2010on\u2010azd7442\u2010storm\u2010chaser\u2010trial.html"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.50.1.46"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323001103900437"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24035"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.13932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tid.13932","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.13932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T10:30:02Z","timestamp":1692527402000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.13932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1111\/tid.13932"],"URL":"https:\/\/doi.org\/10.1111\/tid.13932","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"2022-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13932"}}